Back
New CentoXome

Turning Years Into Days

It takes approx. 7 years to diagnose a patient with a rare disease. With NEW CentoXome®, you can turn those years into days.

Read More

CENTOGENE - Revolutionising Genetic Solutions

Explore how CENTOGENE is revolutionizing genetic solutions for patients worldwide

Know More

Coronavirus Testing With CENTOGENE

Coronavirus Testing With CENTOGENE

Enabling you to get back to normal with our range of SARS-CoV-2 testing solutions for individuals and businesses

Read More

Improved Travel With Coronavirus Testing

The Latest Insights Into COVID-19

Keeping you up to date with the most recent news and scientific developments amid the Coronavirus pandemic

Read More

Our goal: providing precise medical diagnosis of inherited diseases at the earliest possible moment; transforming medical expertise and analytical information into actionable results for physicians, patients, and pharmaceutical partners.

Our commitment: life-long support for our patients and partners - driven by the continuous improvement of our diagnostic quality and therapeutic options for individual patients.

Company Newsletter

Keep up to date with the latest scientific insights and rare disease news
with your monthly digital edition of CentoBrief

Subscribe Now

CAMBRIDGE, Mass. and ROSTOCK, Germany, and BERLIN, July 27, 2021 (GLOBE NEWSWIRE) – Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on...

Weiterlesen

CAMBRIDGE, Mass. and ROSTOCK, Germany, and BERLIN, June 25, 2021 (GLOBE NEWSWIRE) – Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on...

Weiterlesen

CAMBRIDGE, Mass., USA und ROSTOCK & BERLIN, Deutschland, 24. Juni 2021

  • CENTOGENE baut sein Netzwerk an SARS-CoV-2-Testcentern in deutschen Innenstädten und an...
Weiterlesen

CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, June 22, 2021 (GLOBE NEWSWIRE)

Highlights strategic priorities to lead data-driven insights creation for rare...

Weiterlesen

CAMBRIDGE, Mass. and ROSTOCK, Germany, and BERLIN, June 16, 2021 (GLOBE NEWSWIRE)

Further signs of recovery in the core rare disease business

Recorded...

Weiterlesen

CAMBRIDGE, Mass., USA und ROSTOCK & BERLIN, Deutschland, 16. Juni 2021

  • CENTOGENE, ein etablierter Anbieter von umfassenden SARS-CoV-2-Testslösungen, eröffnet...
Weiterlesen

CAMBRIDGE, Mass., USA und ROSTOCK & BERLIN, Deutschland, 11. Juni 2021

  • Das Planen einer Reise, egal ob privater oder beruflicher Natur, ist im Zuge der...
Weiterlesen

CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, June 9, 2020 (GLOBE NEWSWIRE) - Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on...

Weiterlesen